- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bajaj Healthcare secured an expert committee's nod to start Phase III clinical trials for Suvorexant Tablets, an insomnia drug. This is a first for an Indian company, potentially boosting its neurology pipeline.